news

Altair to Showcase AI-Powered Engineering, Smart Manufacturing, and Connected Defense Solutions at DSEI 2025

Highlights will feature how computational intelligence is shaping the future of aerospace and defense TROY, Mich., Sept. 2, 2025 /PRNewswire/…

10 months ago

Jungbunzlauer to acquire from International Flavors & Fragrances, Inc. multipurpose site in Thomson, IL

 – establishing U.S. manufacturing footprint – BASEL, Switzerland, Sept. 2, 2025 /PRNewswire/ -- Jungbunzlauer, a global leader in high-quality, sustainable…

10 months ago

Leading Global and Indian Investors Launch India Deep Tech Investment Alliance

Alliance to spur increased private investment in priority deep tech sectors with $1B USD total capital commitments to date Builds…

10 months ago

Chunghwa Telecom Receives Frost & Sullivan’s 2025 Taiwan Company of the Year Recognition for Excellence in the Telecom Industry

Chunghwa Telecom is recognized for its customer-centric innovation, digital transformation, and sustained strategic execution across Taiwan's telecom landscape. SAN ANTONIO,…

10 months ago

India’s Gaming Reset: New Law Sparks a Turning Point for the Industry, Says Redseer Strategy Consultants

BENGALURU, India, Sept. 2, 2025 /PRNewswire/ -- With over 500 million digital gamers in CY2024, India was on track to…

10 months ago

Diageo India Breaks Ground on The Good Craft Co. Flavour Market in Ponda, Goa

A first-of-its-kind space combining a craft making hub, nanobrewery, innovation lab, startup incubator, retail hub and craft experience centre, it's the…

10 months ago

GGVL Relaunches V21 in 100% Recycled PET — India’s First Beverage Brand to Do So

From turning waste into want, to reshaping what premium looks like — Great Galleon Ventures Limited sets a new benchmark…

10 months ago

FIRST PATIENT DOSED IN CITRYLLS PHASE IIA TRIAL EVALUATING CIT-013 IN RHEUMATOID ARTHRITIS

Randomized multi-center study designed to assess the efficacy, safety, and tolerability of CIT-013 in patients with moderately active rheumatoid arthritis…

10 months ago

CHARM Therapeutics raises $80 million in Series B financing to advance development of best-in-class menin inhibitor for AML

New investors NEA and SR One lead round alongside existing investors OrbiMed, F-Prime, NVIDIA and Khosla VenturesCHARM’s AI-designed menin inhibitor…

10 months ago

Coloplast A/S – Announcement no. 07/2025 – Coloplast announces new financial ambition towards 2030

In relation to the launch of Coloplast’s new 5-year strategy, Impact4, the company announces a new financial ambition with organic revenue…

10 months ago